Capabilities aim to make cancer care simpler, more personalized, and easier to navigate
UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction.
1 Value Stock to Consider Right Now and 2 Facing Headwinds
U.S. stocks ticked higher following strong profit reports from big companies
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.38%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.28%. September...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.64%. September E-mini S&P futures...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.31%. September E-mini S&P futures...
Elevance Health (NYSE:ELV) Reports Bullish Q2 CY2026
2Q 2026 operating revenue of $49.8 billion, up 0.8% from 2Q 2025 2Q 2026 diluted EPS 1 of $6.71 and adjusted diluted...